Open Access
E3S Web Conf.
Volume 308, 2021
2021 6th International Conference on Materials Science, Energy Technology and Environmental Engineering (MSETEE 2021)
Article Number 02018
Number of page(s) 7
Section Environmental Ecology and Biochemical Testing
Published online 27 September 2021
  1. Sabin, A.B., Pathogenesis of Poliomyelitis Reappraisal in the Light of New Data. Science, 1956. 123(3209): p. 1151-1157. [CrossRef] [PubMed] [Google Scholar]
  2. Mehndiratta, M.M., P. Mehndiratta, and R. Pande, Poliomyelitis: historical facts, epidemiology, and current challenges in eradication. The Neurohospitalist, 2014. 4(4): p. 223-229. [CrossRef] [PubMed] [Google Scholar]
  3. Kroon, F.P., et al., Abortive and Subclinical Poliomyelitis in a Family During the 1992 Epidemic in the Netherlands. Clinical Infectious Diseases, 1995. 20(2): p. 454-456. [Google Scholar]
  4. Sathyamala, C., et al., Polio Eradication Initiative in India: Deconstructing the GPEI. International Journal of Health Services, 2005. 35(2): p. 361-383. [Google Scholar]
  5. Nomoto, A., Molecular aspects of poliovirus pathogenesis. Proceedings of the Japan Academy, Series B, 2007. 83(8): p. 266-275. [Google Scholar]
  6. Africa Regional Commission for the Certification of Poliomyelitis Eradication. Certifying the interruption of wild poliovirus transmission in the WHO African region on the turbulent journey to a polio-free world. Lancet Glob Health. 2020 Oct;8(10):e1345-e1351. [CrossRef] [PubMed] [Google Scholar]
  7. Ciapponi A, Bardach A, Rey Ares L, Glujovsky D, Cafferata ML, Cesaroni S, Bhatti A. Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis. Cochrane Database Syst Rev. 2019 Dec 5;12(12):CD011260. [Google Scholar]
  8. Shaghaghi M, Soleyman-Jahi S, Abolhassani H, Yazdani R, Azizi G, Rezaei N, Barbouche MR, McKinlay MA, Aghamohammadi A. New insights into physiopathology of immunodeficiency-associated vaccine-derived poliovirus infection; systematic review of over 5 decades of data. Vaccine. 2018 Mar 20;36(13):1711-1719. [CrossRef] [PubMed] [Google Scholar]
  9. Kalkowska DA, Pallansch MA, Wilkinson A, Bandyopadhyay AS, Konopka-Anstadt JL, Burns CC, Oberste MS, Wassilak SGF, Badizadegan K, Thompson KM. Updated Characterization of Outbreak Response Strategies for 2019-2029: Impacts of Using a Novel Type 2 Oral Poliovirus Vaccine Strain. Risk Anal. 2021 Feb;41(2):329-348. [CrossRef] [PubMed] [Google Scholar]
  10. Patel M, Orenstein W. A World Free of Polio--The Final Steps. N Engl J Med. 2016 Feb 11;374(6):501-3. doi: 10.1056/NEJMp1514467. PMID: 26863350. [CrossRef] [PubMed] [Google Scholar]
  11. Jones Jr, H.R., et al., Netter’s Neurology E-Book. 2011: Elsevier Health Sciences. [Google Scholar]
  12. Julien, J., et al., Postpolio syndrome: poliovirus persistence is involved in the pathogenesis. Journal of Neurology, 1999. 246(6): p. 472-476. [CrossRef] [PubMed] [Google Scholar]
  13. Hogle, J., M. Chow, and D. Filman, Three-dimensional structure of poliovirus at 2.9 A resolution. Science, 1985. 229(4720): p. 1358-1365. [CrossRef] [PubMed] [Google Scholar]
  14. Mendelsohn, C.L., E. Wimmer, and V.R. Racaniello, Cellular receptor for poliovirus: Molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell, 1989. 56(5): p. 855-865. [CrossRef] [PubMed] [Google Scholar]
  15. Koike, S., et al., Transgenic mice susceptible to poliovirus. Proceedings of the National Academy of Sciences, 1991. 88(3): p. 951-955. [Google Scholar]
  16. Chothia, C. and E.Y. Jones, The molecular structure of cell adhesion molecules. Annual review of biochemistry, 1997. 66(1): p. 823-862. [CrossRef] [PubMed] [Google Scholar]
  17. Koike, S., I. Ise, and A. Nomoto, Functional domains of the poliovirus receptor. Proceedings of the National Academy of Sciences, 1991. 88(10): p. 4104-4108. [Google Scholar]
  18. Arita, M., et al., Interaction of Poliovirus with Its Purified Receptor and Conformational Alteration in the Virion. Journal of Virology, 1998. 72(5): p. 3578-3586. [CrossRef] [PubMed] [Google Scholar]
  19. Brady, S.T., Molecular motors in the nervous system. Neuron, 1991. 7(4): p. 521-533. [CrossRef] [PubMed] [Google Scholar]
  20. Tolskaya, E.A., et al., Postinfection treatment with antiviral serum results in survival of neural cells productively infected with virulent poliovirus. Journal of Virology, 1992. 66(8): p. 5152-5156. [CrossRef] [PubMed] [Google Scholar]
  21. Vashishtha VM, Kamath S. A Brief History of Vaccines Against Polio. Indian Pediatr. 2016 Aug 7;53 Suppl 1:S20-S27. [PubMed] [Google Scholar]
  22. Minor P. Vaccine-derived poliovirus (VDPV): Impact on poliomyelitis eradication. Vaccine. 2009 May 5;27(20):2649-52.AS [CrossRef] [PubMed] [Google Scholar]
  23. Verma R, Khanna P, Chawla S. Inactivated polio vaccine: time to introduce it in India’s national immunization schedule. Hum Vaccin Immunother. 2012 Jul;8(7):956-8. Sa [CrossRef] [PubMed] [Google Scholar]
  24. Dabas A, Yadav S. Vaccine Response With OPV: Should We Worry? Indian Pediatr. 2020 Feb 15;57(2):172-173.As [CrossRef] [PubMed] [Google Scholar]
  25. Thompson KM, Kalkowska DA. Logistical challenges and assumptions for modeling the failure of global cessation of oral poliovirus vaccine (OPV). Expert Rev Vaccines. 2019 Jul;18(7):725-736.Sa [CrossRef] [PubMed] [Google Scholar]
  26. Ciapponi A, Bardach A, Rey Ares L, Glujovsky D, Cafferata ML, Cesaroni S, Bhatti A. Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis. Cochrane Database Syst Rev. 2019 Dec 5;12(12):CD011260. [PubMed] [Google Scholar]
  27. Lopalco PL. Wild and vaccine-derived poliovirus circulation, and implications for polio eradication. Epidemiol Infect. 2017 Feb;145(3):413-419. [CrossRef] [PubMed] [Google Scholar]
  28. Mohanty MC, Madkaikar MR, Desai M, Aluri J, Varose SY, Taur P, Sharma DK, Nalavade UP, Rane SV, Gupta M, Shabarish S, Dalvi A, Deshpande JM. Natural Clearance of Prolonged VDPV Infection in a Child With Primary Immunodeficiency Disorder. Front Immunol. 2019 Jul 23; 10: 1567. [CrossRef] [PubMed] [Google Scholar]
  29. Jorba J, Diop OM, Iber J, Henderson E, Zhao K, Quddus A, Sutter R, Vertefeuille JF, Wenger J, Wassilak SGF, Pallansch MA, Burns CC. Update on Vaccine-Derived Poliovirus Outbreaks - Worldwide, January 2018-June 2019. MMWR Morb Mortal Wkly Rep. 2019 Nov 15;68(45):1024-1028. [CrossRef] [PubMed] [Google Scholar]
  30. Nkowane BM, Wassilak SGF, Orenstein WA, et al. Vaccine-Associated Paralytic Poliomyelitis: United States: 1973 Through 1984. JAMA. 1987;257(10):1335–1340. doi:10.1001/jama.1987.03390100073029 [CrossRef] [PubMed] [Google Scholar]
  31. Kramer, S. D., A. G. Gilliam, and J. G. Molner. “Recovery of the Virus of Poliomyelitis from the Stools of Healthy Contacts in an Institutional Outbreak.” Public Health Reports (1896-1970) 54.43(1939):1914-1922. [Google Scholar]
  32. Guyton, A. C.. “Reaction of the Body to Poliomyelitis and the Recovery Process.” Archives of Internal Medicine 83.1(1949):27. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.